Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

11.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

528
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
528
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

924
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
924
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

195
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
195

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hispidin Ameliorates Acute Ultraviolet B-Induced Skin Inflammation by Targeting Reactive Oxygen Species-Dependent Neutrophil Extracellular Trap Formation.

International journal of molecular sciences·2026
Same author

Orally Administered Rhamnan Sulfate from <i>Monostroma nitidum</i> Significantly Inhibits Melanoma Metastasis in Lungs and Aorta of Mice Implanted with B16 Cells.

Marine drugs·2026
Same author

Strain-Dependent and Site-Specific Differences in Irinotecan-Induced Skin Pigmentation in Mice.

Biological & pharmaceutical bulletin·2026
Same author

Effect of Physical Therapy on Vestibular Function in Body Lateropulsion Following Wallenberg Syndrome: A Case Report Using the Modified Clinical Test of Sensory Interaction and Balance.

Cureus·2026
Same author

A Case of Spinal Astroblastoma-Like Neuroepithelial Tumor With MAMLD1::BEND2 Fusion.

Pathology international·2025
Same author

Characteristics of Non-intubated Older Adult Patients With COVID-19 and Decreased Feeding and Swallowing Function and Their Association With Length of Hospital Stay.

Cureus·2025

Related Experiment Video

Updated: Jun 29, 2025

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
12:59

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

12.6K

Interactions between Age-Related Type 2 Diabetes and the Small Intestine.

Masashi Imai1, Keiichi Hiramoto1, Shota Tanaka1

  • 1Department of Pharmaceutical Sciences, Suzuka University of Medical Science.

Biological & Pharmaceutical Bulletin
|April 7, 2024
PubMed
Summary

Type 2 diabetes worsens with age, impacting the small intestine. This study reveals increased advanced glycation end products (AGEs) and inflammation, contributing to diabetic complications.

Keywords:
advanced glycation end producthistaminemast celltumor necrosis factor-αtype 2 diabetes

More Related Videos

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

16.8K
Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

9.7K

Related Experiment Videos

Last Updated: Jun 29, 2025

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
12:59

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

12.6K
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

16.8K
Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

9.7K

Area of Science:

  • Gastroenterology
  • Endocrinology
  • Immunology

Background:

  • Type 2 diabetes mellitus (T2DM) is a growing global health concern.
  • Pathological mechanisms of T2DM in the small intestine are not fully understood.
  • Aging exacerbates T2DM and its complications.

Purpose of the Study:

  • To investigate the age-related pathological mechanisms of T2DM in the small intestine.
  • To identify key molecular and cellular changes associated with T2DM progression in the gut.

Main Methods:

  • Utilized a KK-Ay/TaJcl mouse model of T2DM at 10 and 50 weeks of age.
  • Assessed levels of advanced glycation end products (AGEs), mast cells, diamine oxidase (DAO), tumor necrosis factor-alpha (TNF-α), and histamine.
  • Evaluated the expression of tight junction proteins (ZO-1, Claudin1) and cell adhesion molecules.

Main Results:

  • Diabetes severity increased with age in T2DM mice.
  • Elevated AGEs, mast cell expression, TNF-α, and histamine were observed.
  • Decreased DAO expression and reduced expression of tight junction proteins and cell adhesion molecules were noted.
  • These changes were more pronounced in aged T2DM mice.

Conclusions:

  • T2DM induces AGE/mast cell/histamine and TNF-α signaling in the small intestine.
  • Reduced intestinal barrier integrity allows inflammatory mediators to enter circulation, worsening T2DM.
  • Aging intensifies these pathological processes, exacerbating T2DM and its complications.